Prevalence of systemic lupus erythematosus in Colombia: data from the national health registry 2012–2016

Introduction Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides...

Full description

Saved in:
Bibliographic Details
Published inLupus Vol. 28; no. 10; pp. 1273 - 1278
Main Authors Fernández-Ávila, D G, Bernal-Macías, S, Rincón-Riaño, D N, Gutiérrez Dávila, J M, Rosselli, D
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.09.2019
Sage Publications Ltd
Subjects
Online AccessGet full text
ISSN0961-2033
1477-0962
1477-0962
DOI10.1177/0961203319864168

Cover

More Information
Summary:Introduction Registries are essential to keep track of systemic lupus erythematosus (SLE) epidemiology and to provide better care to patients. The Colombian Ministry of Health has adopted a registry (SISPRO) to gather comprehensive information coming from the Colombian health system, which provides close to universal coverage (around 95%). The information collected from SISPRO is available for scientific analysis. Objectives We used data collected by SISPRO to estimate prevalence and specific characteristics of patients with SLE registered from January 2012 to December 2016. Methods This is a descriptive epidemiological study using the International Statistical Classification of Diseases and Related Health Problems as search terms related to SLE, based on SISPRO data. Criteria for diagnosis are not explicitly addressed in each individual case. Results National records report 41,804 patients with a diagnosis of SLE for an estimated prevalence of 91.9/100,000 subjects (based on a total population of 47,663,162), being more frequent in women (89% cases). When adjusted, female and male prevalences were 204.3 and 20.2 per 100,000 (ratio 10.1) with a 7.9:1 female:male ratio, and were highest in the 45–49-year age group. Conclusions This is the first study that describes demographic characteristics of SLE in Colombia, with useful information for decision makers. It also suggests a similar prevalence to other countries.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0961-2033
1477-0962
1477-0962
DOI:10.1177/0961203319864168